PAS
MIRM icon

Point72 Asia (Singapore)’s Mirum Pharmaceuticals MIRM Stock Holding History

Point72 Asia (Singapore)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-856
Closed -$35.4K – 1076
2024
Q4 		$35.4K Buy
+856
New +$35.7K 0.01% 571

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asia (Singapore)'s MIRM Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Mirum Pharmaceuticals (MIRM) in Q1 2025, closing a stake of 856 shares — an estimated $35.4K sold.

Point72 Asia (Singapore) first reported a position in MIRM in Q4 2024 and held it in 1 quarter. The position peaked at $35.4K in Q4 2024. 214 funds tracked by Wall St. Rank hold MIRM as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Mirum Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 856 Mirum Pharmaceuticals shares in Q1 2025, an estimated $35.4K.
  • Point72 Asia (Singapore) first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Mirum Pharmaceuticals position peaked at $35.4K in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.